Oct 22// Cerba & Taliaz to Leverage AI and Genetics Experience to Improve Patient Care Management in Depression
Saint Ouen l’Aumône (France) and Tel Aviv (Israel), October 20th, 2022 – Cerba, the foremost specialty clinical pathology reference, and Taliaz, an Israeli digital health company dedicated to...
Oct 22 // New UK-Israel collaboration to bring innovative mental health treatment solutions to the NHS in the UK
Grounded Research, the research team at Rotherham Doncaster and South Humber(RDaSH) NHS Foundations Trust, is announcing a ground-breaking collaborationwith Israeli digital health company, Taliaz....
The use of smartphones and wearable devices to continuously and objectively collect quantified behavioral data from patients by utilizing digital biomarkers of mental disorder symptoms. This quantified data can be used to determine a patient’s diagnosis and personalized treatment, and thereby allow a personalized treatment for each patient.
May 21 // Taliaz Announces Successful End of Enrollment to its PREDICTIX Mental Health Study with Leading French Hospital, APHP
New study provides psychiatrists with pioneering clinical support tool to inform antidepressant prescribing enabling improved quality of care, while saving time and lowering costs.Tel Aviv, Israel,...
Taliaz, announced today the successful end of patient enrollment in the PREDICTIX mental health study at APHP, a leading hospital in France. Assistance Publique – Hôpitaux de Paris (APHP).
Taliaz appoints leading European psychiatrists, Professor Alessandro Serretti and Dr. Daniel Souery to its Advisory Board.
The study revealed that 78% of the global workforce aged 22 to 74 feels higher levels of daily stress and anxiety than ever before. Israeli mental health startup Taliaz recently received CE (European Union) approval for PREDICTIX Digital, an artificial intelligence (AI) tool providing instant digital prescribing recommendations during a patient’s face-to-face or virtual visit.
Taliaz, has announced that it has entered into a three-year partnership agreement with molecular diagnostics leader, Genetic Technologies Ltd for the distribution of its PREDICTIX products, Genetics and Digital, in Australia, New Zealand and the USA, pending regulatory approval.
+972 (0)77 335 2506
2 Prof. Yehezkel Kaufmann St. Tel Aviv-Yafo, Israel
Let's help patients recover sooner with PREDICTIX